sharecast

{{ storiesRelated.title }}

Latest News
05 Sep
asthma, health
Breezhaler better than Seretide, says Vectura

Inhaled airways disease focused pharmaceuticals company Vectura Group confirmed an announcement from its alliance partner Novartis on Monday, that new analyses from the head-to-head FLAME study confirmed that Ultibro Breezhaler is a “more effective option” for patients at risk of chronic obstructive pulmonary disease flare-ups than Seretide.

05 Sep
Carr's Milling industries, flour, Carrs, food
Carr's to return £16m to shareholders after food division disposal

Agriculture, food and engineering firm Carr’s Group has sold its food division, Carr’s Flour Mills, to flour milling business Whitworths for £36m.

05 Sep
wizz air wizzair airbus aircraft plane a320
Wizz Air's passenger numbers rise 17% in August

Budget airline Wizz Air increased passenger numbers by 16. 6% in August as it announced new routes to and from several central and eastern European countries and launched a new website.

05 Sep
carillion sign
Carillion extends partnership with Centrica for £90m

Construction and maintenance company Carillion extended its partnership with utility firm Centrica for a further five years to deliver facilities management and project services, in a deal worth £90m.

05 Sep
edgar test 10
Dechra Pharmaceuticals revenue up following acquisitions

Dechra Pharmaceuticals reported a jump in underlying profit for the year as revenue grew following a number of acquisitions.

05 Sep
noticias
Monday newspaper round-up: Brexit delay, UK fracking, BAE Systems

Banks are demanding up to five years to deal with the consequences of Britain’s departure from the European Union, a move that if successful could prompt accusations of favouritism and incur the wrath of those campaigning for a swift exit. Britain’s lenders are pressing to be allowed up to three further years to arrange their affairs for Brexit on top of the two-year period that will be triggered when Theresa May invokes Article 50. They say they need more time because of the complexities of having to move big operations away from the UK.

05 Sep
DFS Enfield LondonMetric
LondonMetric sells retail park, buys warehouse

LondonMetric Property announced on Monday that it has sold a retail park in Warrington for £6. 6m, at a net initial yield of 5. 4%, and acquired an 89,000 sq ft distribution warehouse in Hemel Hempstead for £8. 3m, at a net initial yield 6. 4%.

05 Sep
London, city, DL
London pre-open: Stocks seen higher ahead of services PMI

London stocks were expected to open higher on Monday following an upbeat session in Asia, as investors eye the release of UK services data.

05 Sep
pharma, biotech, drugs, lab, gsk, glaxo, trials,  clinical
GlaxoSmithKline's Relvar Ellipta shows 'significant' test score for COPD

Tests of a GlaxoSmithKline respiratory drug have found a statistically significant reduction in the rate of attacks suffered by chronic obstructive pulmonary disease (COPD) patients compared to when they receive the standard treatment.